Twenty Years of Pancreatic Surgery in Iceland
1 other identifier
observational
244
0 countries
N/A
Brief Summary
A retrospective analysis of patients undergoing pancreatic operations in Landspitali University Hospital, Reykjavik, Iceland, between 2003 and 2022.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 12, 2024
CompletedFirst Posted
Study publicly available on registry
December 18, 2024
CompletedDecember 24, 2024
December 1, 2024
19.9 years
December 12, 2024
December 19, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Severe complications
2003-2022
Short-term mortality
2003-2022
Secondary Outcomes (6)
Demographic, operative and postoperative data
2003-2022
Oncological data and survival among patients with pancreatic and periampullary cancer
2003-2022
Outcomes after pancreatic surgery among patients who underwent resection for cystic lesions
2003-2022
Comparison of patients who underwent minimally invasive distal pancreatectomy during the study period to those who underwent open distal resection.
2003-2022
Demographic and histopathological data as well as survival compared between patients with duodenal cancer who underwent resection and patients who did not.
2003-2022
- +1 more secondary outcomes
Eligibility Criteria
All patients who have undergone pancreatic resection in Iceland between 2003-2022. For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
You may qualify if:
- All patients who have undergone pancreatic resection in Iceland between 2003-2022.
- For the secondary outcome of duodenal cancer, patients with duodenal cancer who did not undergo resection in the same time span will also be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linkoeping Universitylead
- Landspitali University Hospitalcollaborator
Related Publications (1)
Johansen K, Birgisson G, Haraldsdottir KH. Early implementation of laparoscopic left-sided pancreatectomy in a tertiary low-volume hospital. Scand J Surg. 2025 Sep;114(3):334-341. doi: 10.1177/14574969251343471. Epub 2025 May 26.
PMID: 40417843DERIVED
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Principal investigator
Study Record Dates
First Submitted
December 12, 2024
First Posted
December 18, 2024
Study Start
January 1, 2003
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Not included in the ethical approval for the study.